Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATP4A | P20648 | 9/20 | 0.66 |
| ▸ | ATP4B | P51164 | 9/20 | 0.66 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 5/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.48 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.48 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6327086 | 0.93 | ATP4A (0.64) | ATP4AATP4BGAARAB9AMAPT | |
| SCHEMBL6329454 | 0.86 | ATP4A (0.57) | ATP4AATP4BGAARAB9AMAPT | |
| SCHEMBL19626566 | 0.85 | ATP4A (0.65) | ATP4AATP4BGAARAB9AMAPT | |
| SCHEMBL8113094 | 0.84 | ATP4A (0.64) | ATP4AATP4BGAARAB9AMAPT | |
| SCHEMBL2809395 | 0.81 | GAA (0.74) | ATP4AATP4BGAARAB9AMAPT | |
| SCHEMBL727280 | 0.80 | PRMT1 (0.58) | ATP4AATP4B | |
| SCHEMBL10656922 | 0.80 | ATP4A (1.00) | ATP4AATP4B | |
| SCHEMBL10459082 | 0.79 | ATP4A (0.56) | ATP4AATP4BGAARAB9AMAPT | |
| SCHEMBL6336181 | 0.77 | MAPT (0.49) | ATP4AATP4BRAB9AMAPTMEN1 | |
| SCHEMBL10457438 | 0.77 | ATP4A (0.56) | ATP4AATP4BGAARAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200087248-A1 | Fluoroallylamine Derivative And Use Thereof | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) | 2020-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200087248-A1 | Fluoroallylamine Derivative And Use Thereof | VAPB, VAPA, SLC28A1 | ATP4A 945/4885ATP4B 2031/4885GAA 237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.